1-16 of 16
Mark Kester
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2079: Ceramide nanoliposomes a novel therapeutic option for androgen receptor negative prostate cancer

Pedro Costa-Pinheiro, Abigail Heher, Michael Raymond, Kasey Jividen, Todd Fox, Mark Kester
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2079.
https://doi.org/10.1158/1538-7445.AM2020-2079
Published: 15 August 2020
View article titled, Abstract 2079: Ceramide nanoliposomes a novel therapeutic option for androgen receptor negative prostate cancer
Journal Articles

Abstract 5832: Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia

Charyguly Annageldiyev, Arati Sharma, Brian M. Barth, Todd E. Fox, Tye Deering, Viola Devine, Nicole R. Keasey, Stephan T. Stern, Megan M. Young, Hong-Gang Wan Wang, Jason Liao, Junjia Zhu, Aaron D. Viny, Ross L. Levine, Thomas P. Loughran, Mark Kester, David F. Claxton
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5832.
https://doi.org/10.1158/1538-7445.AM2018-5832
Published: 01 July 2018
View article titled, Abstract 5832: Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia
Journal Articles

Abstract 3083A: C6-ceramide nanoliposomes sensitize paclitaxel resistant ovarian cancer cells to chemotherapy treatment

Danielle C. Llaneza, Tye G. Deering, Samantha G. Sherwood, John R. Cornelison, Mark Kester, Charles N. Landen
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3083A.
https://doi.org/10.1158/1538-7445.AM2017-3083A
Published: 01 July 2017
View article titled, Abstract 3083A: C6-ceramide nanoliposomes sensitize paclitaxel resistant ovarian cancer cells to chemotherapy treatment
Journal Articles

Abstract 323: SKI-178, a single agent co-targeting sphingosine kinase 1 and microtubule dynamics, as a therapeutic strategy for treatment of acute myeloid leukemia

Taryn E. Dick, Jeremy A. Hengst, Laura M. Geffert, Robert F. Paulson, Hong-Gang Wang, David F. Claxton, Mark Kester, Thomas P. Loughran, Jong K. Yun
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 323.
https://doi.org/10.1158/1538-7445.AM2016-323
Published: 15 July 2016
View article titled, Abstract 323: SKI-178, a single agent co-targeting sphingosine kinase 1 and microtubule dynamics, as a therapeutic strategy for treatment of acute myeloid leukemia
Journal Articles

Abstract 2613: STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia via the MEK/ERK and PKC pathway

Ushma Atul Doshi, Thomas P. Loughran, Mark Kester
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2613.
https://doi.org/10.1158/1538-7445.AM2015-2613
Published: 01 August 2015
View article titled, Abstract 2613: STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia via the MEK/ERK and PKC pathway
Journal Articles

Abstract 2803: Oral administration of an acid stable liposomal formulation of docosahexaenoic acid (DHA) delivers DHA and its LOX-metabolites to the circulation and the breast tissue of sprague dawley rats

Christine G. Skibinski, Arunangshu Das, Kun-Ming Chen, Neil Trushin, Bogdan Prokopczyk, Cesar Aliaga, Mark Kester, Andrea Manni, Karam El-Bayoumy
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2803.
https://doi.org/10.1158/1538-7445.AM2015-2803
Published: 01 August 2015
View article titled, Abstract 2803: Oral administration of an acid stable liposomal formulation of docosahexaenoic acid (DHA) delivers DHA and its LOX-metabolites to the circulation and the breast tissue of sprague dawley rats
Journal Articles

Abstract 5421: A novel biologically active acid stable liposomal formulation of docosahexaenoic acid (DHA) for breast cancer prevention

Christine Gail Skibinski, Arunangshu Das, Mark Kester, Kun-Min Chen, Andrea Manni, Karam El-Bayoumy
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5421.
https://doi.org/10.1158/1538-7445.AM2014-5421
Published: 01 October 2014
View article titled, Abstract 5421: A novel biologically active acid stable liposomal formulation of docosahexaenoic acid (DHA) for breast cancer prevention
Journal Articles

Abstract 5404: C6-ceramide containing anionic nanoliposomes are effective chemotherapy delivery vehicles for pancreatic cancer

Christopher McGovern, Sriram Shanmugavelandy, Sara Shimko, Samuel Linton, Jenny Dai, Mark Kester, Jill P. Smith, Gail L. Matters
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5404.
https://doi.org/10.1158/1538-7445.AM2014-5404
Published: 01 October 2014
View article titled, Abstract 5404: C6-ceramide containing anionic nanoliposomes are effective chemotherapy delivery vehicles for pancreatic cancer
Journal Articles

Abstract 2027: Tamoxifen amplifies antitumor impact of nanoformulated ceramide- pan efficacy in a myriad of tumor cell types.

Samy A.F. Morad, Jonathan C. Levin, Noha Abdelmageed, Mark Kester, Sriram S. Shanmugavdlandy, Robert F. Paulson, Daniel W. Rosenberg, James P. Madigan, Myles C. Cabot
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2027.
https://doi.org/10.1158/1538-7445.AM2013-2027
Published: 15 April 2013
View article titled, Abstract 2027: Tamoxifen amplifies antitumor impact of nanoformulated ceramide- pan efficacy in a myriad of tumor cell types.
Journal Articles

Abstract 3833: Ceramide/tamoxifen nanoliposomal combination - A promising strategy for treatment of chemoresistant breast cancer

Samy A.F. Morad, Jonathan C. Levin, Mark Kester, Sriram S. Shanmugavelandy, Myles C. Cabot
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3833.
https://doi.org/10.1158/1538-7445.AM2012-3833
Published: 15 April 2012
View article titled, Abstract 3833: Ceramide/tamoxifen nanoliposomal combination - A promising strategy for treatment of chemoresistant breast cancer
Journal Articles

Abstract 4302: Targeting the sphingolipid pathway in NK large granular lymphocyte leukemia

Rebecca J. Watters, Xin Liu, Todd E. Fox, Mark Kester, Thomas P. Loughran
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4302.
https://doi.org/10.1158/1538-7445.AM2011-4302
Published: 15 April 2011
View article titled, Abstract 4302: Targeting the sphingolipid pathway in NK large granular lymphocyte leukemia
Journal Articles

Abstract 4132: Down Regulation of the CCK-B/C Receptor Inhibits Growth of Pancreatic Cancer

Kristin K. Fino, Gail L. Matters, Christopher O. McGovern, Mark Kester, Jill P. Smith
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4132.
https://doi.org/10.1158/1538-7445.AM10-4132
Published: 15 April 2010
View article titled, Abstract 4132: Down Regulation of the CCK-B/C Receptor Inhibits Growth of Pancreatic Cancer
Journal Articles

Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development

Melissa A. Tran, Raghavendra Gowda, Arati Sharma, Eun-Joo Park, James Adair, Mark Kester, Nadine Barrie Smith, Gavin P. Robertson
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7638–7649.
https://doi.org/10.1158/0008-5472.CAN-07-6614
Published: 14 September 2008
View article titled, Targeting <sup>V600E</sup>B-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
Open the PDF for Targeting <sup>V600E</sup>B-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development in another window
Journal Articles

A combinatorial approach using sorafenib and liposomal ceramide to inhibit malignant melanoma

Melissa Tran, Arati Sharma, Charles Smith, Mark Kester, Gavin Robertson
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4754.
Published: 01 May 2007
View article titled, A combinatorial approach using sorafenib and liposomal ceramide to inhibit malignant melanoma
Journal Articles

Deregulated Akt3 Activity Promotes Development of Malignant Melanoma

Jill M. Stahl, Arati Sharma, Mitchell Cheung, Melissa Zimmerman, Jin Q. Cheng, Marcus W. Bosenberg, Mark Kester, Lakshman Sandirasegarane, Gavin P. Robertson
Journal: Cancer Research
Cancer Res (2004) 64 (19): 7002–7010.
https://doi.org/10.1158/0008-5472.CAN-04-1399
Published: 01 October 2004
View article titled, Deregulated Akt3 Activity Promotes Development of Malignant Melanoma
Open the PDF for Deregulated Akt3 Activity Promotes Development of Malignant Melanoma in another window
Journal Articles

In vivo antineoplastic efficacy of ceramide via novel drug delivery systems

Thomas C. Stover, Mark Kester
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 888.
Published: 01 April 2004
View article titled, <em>In vivo</em> antineoplastic efficacy of ceramide via novel drug delivery systems